Eradicating biofilm infections: an update on current and prospective approaches

Current Opinion in Microbiology - Tập 63 - Trang 117-125 - 2021
Ronni A G da Silva1,2, Irina Afonina1,2, Kimberly A Kline1,2,3
1Singapore-MIT Alliance for Research and Technology, Antimicrobial Drug Resistance Interdisciplinary Research Group, Singapore
2Singapore Centre for Environmental Life Science Engineering, Nanyang Technological University, Singapore
3School of Biological Sciences, Nanyang Technological University, Singapore

Tài liệu tham khảo

Stoodley, 2002, Biofilms as complex differentiated communities, Annu Rev Microbiol, 56, 187, 10.1146/annurev.micro.56.012302.160705 Flemming, 2010, The biofilm matrix, Nat Rev Microbiol, 8, 623, 10.1038/nrmicro2415 Costerton, 1987, Bacterial biofilms in nature and disease, Annu Rev Microbiol, 41, 435, 10.1146/annurev.mi.41.100187.002251 Khatoon, 2018, Bacterial biofilm formation on implantable devices and approaches to its treatment and prevention, Heliyon, 4, 10.1016/j.heliyon.2018.e01067 Levin, 2006, Non-inherited antibiotic resistance, Nat Rev Microbiol, 4, 556, 10.1038/nrmicro1445 Gefen, 2009, The importance of being persistent: heterogeneity of bacterial populations under antibiotic stress: review article, FEMS Microbiol Rev, 33, 704, 10.1111/j.1574-6976.2008.00156.x Stewart, 2008, Physiological heterogeneity in biofilms, Nat Rev Microbiol, 6, 199, 10.1038/nrmicro1838 National Institutes of Health, 2002 Jamal, 2018, Bacterial biofilm and associated infections, J Chinese Med Assoc, 81, 7, 10.1016/j.jcma.2017.07.012 Jamal, 2018, Bacterial biofilm and associated infections, J Chin Med Assoc, 81, 7, 10.1016/j.jcma.2017.07.012 Francolini, 2017, Antifouling and antimicrobial biomaterials: an overview, APMIS, 125, 392, 10.1111/apm.12675 Li, 2018, Recent developments in smart antibacterial surfaces to inhibit biofilm formation and bacterial infections, J Mater Chem B, 6, 4274, 10.1039/C8TB01245H Castaneda, 2016, Biofilm antimicrobial susceptibility increases with antimicrobial exposure time, Clin Orthop Relat Res, 474, 1659, 10.1007/s11999-016-4700-z Dekker, 2019, Do antibiotic-impregnated calcium sulfate beads improve the healing of neuropathic foot ulcers with osteomyelitis undergoing surgical debridement?, Wounds, 31, 145 Meddings, 2010, Systematic review and meta-analysis: reminder systems to reduce catheter-associated urinary tract infections and urinary catheter use in hospitalized patients, Clin Infect Dis, 51, 550, 10.1086/655133 Khansa, 2019, Silver in wound care - friend or foe?: a comprehensive review, Plast Reconstr Surg Glob Open, 7, 10.1097/GOX.0000000000002390 Chen, 2018, Antibacterial dental restorative materials: a review - PubMed, Am J Dent, 31, 6b Sharma, 2019, Antibiotics versus biofilm: an emerging battleground in microbial communities, Antimicrob Resist Infect Control, 8, 1, 10.1186/s13756-019-0533-3 Algburi, 2017, Control of biofilm formation: antibiotics and beyond, Appl Environ Microbiol, 83 Herrmann, 2010, Colistin-tobramycin combinations are superior to monotherapy concerning the killing of biofilm Pseudomonas aeruginosa, J Infect Dis, 202, 1585, 10.1086/656788 Chai, 2019, Evaluation of co-delivery of colistin and ciprofloxacin in liposomes using an in vitro human lung epithelial cell model, Int J Pharm, 569, 10.1016/j.ijpharm.2019.118616 Sahni, 2016, Exploring mechanisms of biofilm removal, Dentistry, 06, 10.4172/2161-1122.1000371 Schiessler, 2019, Donʼt have a doubt, get the catheter out, Pediatr Qual Saf, 4 Manna, 2020 Raad, 2016, Successful salvage of central venous catheters in patients with catheter-related or central line-associated bloodstream infections by using a catheter lock solution consisting of minocycline, EDTA, and 25% ethanol, Antimicrob Agents Chemother, 60, 3426, 10.1128/AAC.02565-15 Jiang, 2020, Targeting biofilms therapy: current research strategies and development hurdles, Microorganisms, 8, 1, 10.3390/microorganisms8081222 Rumbaugh, 2020, Biofilm dispersion, Nat Rev Microbiol, 18, 571, 10.1038/s41579-020-0385-0 Liu, 2020, Encapsulated DNase improving the killing efficiency of antibiotics in staphylococcal biofilms, J Mater Chem B, 8, 4395, 10.1039/D0TB00441C Mugita, 2017, Proteases, actinidin, papain and trypsin reduce oral biofilm on the tongue in elderly subjects and in vitro, Arch Oral Biol, 82, 233, 10.1016/j.archoralbio.2017.04.035 Koo, 2017, Targeting microbial biofilms: current and prospective therapeutic strategies, Nat Rev Microbiol, 15, 740, 10.1038/nrmicro.2017.99 Solano, 2014, Biofilm dispersion and quorum sensing, Curr Opin Microbiol, 18, 96, 10.1016/j.mib.2014.02.008 Howlin, 2017, Low-dose nitric oxide as targeted anti-biofilm adjunctive therapy to treat chronic Pseudomonas aeruginosa infection in cystic fibrosis, Mol Ther, 25, 2104, 10.1016/j.ymthe.2017.06.021 Fleming, 2017, Approaches to dispersing medical biofilms, Microorganisms, 5, 15, 10.3390/microorganisms5020015 Wille, 2020, Biofilm dispersion: the key to biofilm eradication or opening Pandora’s box?, Biofilm, 2, 10.1016/j.bioflm.2020.100027 Cheung, 2021, Bacterial virulence plays a crucial role in MRSA sepsis, PLoS Pathog, 17, 10.1371/journal.ppat.1009369 Theuretzbacher, 2020, The global preclinical antibacterial pipeline, Nat Rev Microbiol, 18, 275, 10.1038/s41579-019-0288-0 Stokes, 2020, A deep learning approach to antibiotic discovery, Cell, 180, 688, 10.1016/j.cell.2020.01.021 Blair, 2020, Modular synthesis enables molecular ju-jitsu in the fight against antibiotic resistance, Nature, 586, 32, 10.1038/d41586-020-02565-1 Luna, 2020, A nutrient-limited screen unmasks rifabutin hyperactivity for extensively drug-resistant Acinetobacter baumannii, Nat Microbiol, 5, 1134, 10.1038/s41564-020-0737-6 Singh, 2021, IspH inhibitors kill Gram-negative bacteria and mobilize immune clearance, Nature, 589, 597, 10.1038/s41586-020-03074-x Chung, 2017, Antimicrobial peptides as potential anti-biofilm agents against multidrug-resistant bacteria, J Microbiol Immunol Infect, 50, 405, 10.1016/j.jmii.2016.12.005 Thappeta, 2020, Combined efficacy of an antimicrobial cationic peptide polymer with conventional antibiotics to combat multidrug-resistant pathogens, ACS Infect Dis, 6, 1228, 10.1021/acsinfecdis.0c00016 Eckert, 2006, Enhancement of antimicrobial activity against Pseudomonas aeruginosa by coadministration of G10KHc and tobramycin, Antimicrob Agents Chemother, 50, 3833, 10.1128/AAC.00509-06 Cirioni, 2006, Pre-treatment of central venous catheters with the cathelicidin BMAP-28 enhances the efficacy of antistaphylococcal agents in the treatment of experimental catheter-related infection, Peptides, 27, 2104, 10.1016/j.peptides.2006.03.007 Antonoplis, 2018, A dual-function antibiotic-transporter conjugate exhibits superior activity in sterilizing MRSA biofilms and killing persister cells, J Am Chem Soc, 140, 16140, 10.1021/jacs.8b08711 Brives, 2020, Phage therapy as a potential solution in the fight against AMR: obstacles and possible futures, Palgrave Commun, 6, 1, 10.1057/s41599-020-0478-4 Pires, 2016, Bacteriophage-encoded depolymerases: their diversity and biotechnological applications, Appl Microbiol Biotechnol, 100, 2141, 10.1007/s00253-015-7247-0 Forti, 2018, Design of a broad-range bacteriophage cocktail that reduces Pseudomonas aeruginosa biofilms and treats acute infections in two animal models, Antimicrob Agents Chemother, 62, 10.1128/AAC.02573-17 Maszewska, 2018, Use of polyvalent bacteriophages to combat biofilm of Proteus mirabilis causing catheter-associated urinary tract infections, J Appl Microbiol, 125, 1253, 10.1111/jam.14026 Seth, 2013, Bacteriophage therapy for staphylococcus aureus biofilm-infected wounds: a new approach to chronic wound care, Plast Reconstr Surg, 131, 225, 10.1097/PRS.0b013e31827e47cd Szafrański, 2017, The use of bacteriophages to biocontrol oral biofilms, J Biotechnol, 250, 29, 10.1016/j.jbiotec.2017.01.002 Testa, 2019, Spatial structure affects phage efficacy in infecting dual-strain biofilms of Pseudomonas aeruginosa, Commun Biol, 2, 1, 10.1038/s42003-019-0633-x Simmons, 2020, Biofilm structure promotes coexistence of phage-resistant and phage-susceptible bacteria, mSystems, 5, 10.1128/mSystems.00877-19 Ferriol-González, 2020, Phages for biofilm removal, Antibiotics, 9, 10.3390/antibiotics9050268 Binte Muhammad Jai, 2020, Engineered lysins with customized lytic activities against Enterococci and Staphylococci, Front Microbiol, 11, 10.3389/fmicb.2020.574739 Indiani, 2019, The antistaphylococcal lysin, CF-301, activates key host factors in human blood to potentiate methicillin-resistant Staphylococcus aureus bacteriolysis, Antimicrob Agents Chemother, 63, 10.1128/AAC.02291-18 Raafat, 2019, Fighting Staphylococcus aureus biofilms with monoclonal antibodies, Trends Microbiol, 27, 303, 10.1016/j.tim.2018.12.009 Domanski, 2005, Characterization of a humanized monoclonal antibody recognizing clumping factor A expressed by Staphylococcus aureus, Infect Immun, 73, 5229, 10.1128/IAI.73.8.5229-5232.2005 Tursi, 2020, Salmonella Typhimurium biofilm disruption by a human antibody that binds a pan-amyloid epitope on curli, Nat Commun, 11, 1007, 10.1038/s41467-020-14685-3 Mokrzan, 2020, Nontypeable Haemophilus influenzae newly released (NRel) from biofilms by antibody-mediated dispersal versus antibody-mediated disruption are phenotypically distinct, Biofilm, 2, 10.1016/j.bioflm.2020.100039 Martyn, 2020, Antibodies against the DNABII protein integration host factor (IHF) inhibit sinus implant biofilms, Laryngoscope, 130, 1364, 10.1002/lary.28188 Novotny, 2020, Targeting a bacterial DNABII protein with a chimeric peptide immunogen or humanised monoclonal antibody to prevent or treat recalcitrant biofilm-mediated infections, EBioMedicine, 59, 10.1016/j.ebiom.2020.102867 Menzel, 2018, Nanobody-based biologics for modulating purinergic signaling in inflammation and immunity, Front Pharmacol, 9, 266, 10.3389/fphar.2018.00266 Micoli, 2021, The role of vaccines in combatting antimicrobial resistance, Nat Rev Microbiol, 19, 287, 10.1038/s41579-020-00506-3 Novotny, 2019, Redirecting the immune response towards immunoprotective domains of a DNABII protein resolves experimental otitis media, npj Vaccines, 4, 1, 10.1038/s41541-019-0137-1 Khalil, 2016, The future of cancer treatment: Immunomodulation, CARs and combination immunotherapy, Nat Rev Clin Oncol, 13, 273, 10.1038/nrclinonc.2016.25 Yamada, 2019, Biofilm-leukocyte cross-talk: impact on immune polarization and immunometabolism, J Innate Immun, 11, 280, 10.1159/000492680 Thurlow, 2011, Staphylococcus aureus biofilms prevent macrophage phagocytosis and attenuate inflammation in vivo, J Immunol, 186, 6585, 10.4049/jimmunol.1002794 Wyatt Shields, 2020, Cellular backpacks for macrophage immunotherapy, Sci Adv, 6 Gupta, 2019, Combatting antibiotic-resistant bacteria using nanomaterials, Chem Soc Rev, 48, 415, 10.1039/C7CS00748E Jardeleza, 2015, An in vivo safety and efficacy demonstration of a topical liposomal nitric oxide donor treatment for Staphylococcus aureus biofilm-associated rhinosinusitis, Transl Res, 166, 683, 10.1016/j.trsl.2015.06.009 Pletzer, 2016, Anti-biofilm peptides as a new weapon in antimicrobial warfare, Curr Opin Microbiol, 33, 35, 10.1016/j.mib.2016.05.016 Jo, 2016, Aptamer-nanoparticle complexes as powerful diagnostic and therapeutic tools, Exp Mol Med, 48, 10.1038/emm.2016.44 Gao, 2016, Nanocatalysts promote Streptococcus mutans biofilm matrix degradation and enhance bacterial killing to suppress dental caries in vivo, Biomaterials, 101, 272, 10.1016/j.biomaterials.2016.05.051 Deacon, 2015, Antimicrobial efficacy of tobramycin polymeric nanoparticles for Pseudomonas aeruginosa infections in cystic fibrosis: formulation, characterisation and functionalisation with dornase alfa (DNase), J Control Release, 198, 55, 10.1016/j.jconrel.2014.11.022 Tasia, 2020, Enhanced eradication of bacterial biofilms with DNase I-loaded silver-doped mesoporous silica nanoparticles, Nanoscale, 12, 2328, 10.1039/C9NR08467C Wang, 2020, Lipid-based antimicrobial delivery-systems for the treatment of bacterial infections, Front Chem, 7, 872, 10.3389/fchem.2019.00872 Clancy, 2013, Phase II studies of nebulised Arikace in CF patients with Pseudomonas aeruginosa infection, Thorax, 68, 818, 10.1136/thoraxjnl-2012-202230 Cipolla, 2016, Development of liposomal ciprofloxacin to treat lung infections, Pharmaceutics, 8, 10.3390/pharmaceutics8010006 Zhou, 2017, In vivo anti-biofilm and anti-bacterial non-leachable coating thermally polymerized on cylindrical catheter, ACS Appl Mater Interfaces, 9, 36269, 10.1021/acsami.7b07053 Ahmed, 2019, Adaptive antibacterial biomaterial surfaces and their applications, Mater Today Bio, 2 Narayana, 2020, A review on surface modifications and coatings on implants to prevent biofilm, Regen Eng Transl Med, 6, 330, 10.1007/s40883-019-00116-3 Khanmohammadi Chenab, 2019, Superhydrophobicity: advanced biological and biomedical applications, Biomater Sci, 7, 3110, 10.1039/C9BM00558G Afonina, 2020, Multiplex crispri system enables the study of stage-specific biofilm genetic requirements in Enterococcus faecalis, mBio, 11, 1, 10.1128/mBio.01101-20 Noirot-Gros, 2019, CRISPR interference to interrogate genes that control biofilm formation in Pseudomonas fluorescens, Sci Rep, 9, 1, 10.1038/s41598-019-52400-5